AstraZeneca is a global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom, dedicated to the discovery, development and commercialisation of prescription medicines. With more than 83,000 employees and operations in over 100 countries, its treatments reach millions of patients worldwide. The company currently has 171 projects in clinical development, 10 molecules in the final stages of development and over 800 active research collaborations across the globe.

AstraZeneca’s operations are structured around sustainable strategic priorities that drive both scientific innovation and commercial success. The company focuses on three main therapeutic areas: Oncology and Hematology, BioPharmaceuticals, which include cardiovascular, renal, as well as metabolic diseases and respiratory, immunology and vaccines.

Beyond its scientific leadership, AstraZeneca is strongly committed to sustainability and environmental protection. Through its Ambition Zero Carbon strategy and nature-based initiatives, the company works to reduce its environmental footprint while contributing to the preservation and restoration of local ecosystems. Sustainability is embedded in every aspect of AstraZeneca’s operations, reflecting its holistic approach to improving both human and planetary health. By integrating innovation, responsibility and long-term vision, AstraZeneca continues to deliver transformative medicines while promoting a healthier and more sustainable future for all.